#20 Strategies for initiating insulin in Type 2 Diabetics
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
- 4T study1: Followed 708 patients for 3 years comparing long-acting basal insulin once daily, biphasic premixed insulin twice daily or prandial insulin with meals.1
- HbA1c levels were not significantly different between the three groups,
- Significantly more patients in the basal and prandial groups attained HbA1c ≤7.0% (63% and 67% versus 49% biphasic).
- Basal insulin had statistically significant:
- Less weight gain (3.6kg) than prandial (6.4kg) or biphasic insulin (5.7kg),
- Fewer confirmed symptomatic hypoglycemic events/person/yr (1.7 basal versus 3.0 biphasic, versus 5.7 prandial),
- More patients requiring a second type of insulin (82% basal, 74% prandial and 68% biphasic),
- Higher total dose of insulin (by weight).
- HbA1c levels were not significantly different between the three groups,
- The four remaining studies (APOLLO2, INITIATE3 JDDM 114, and Riddle5) followed 160 to 588 patients for 6-14 months and compared basal to prandial,2 basal to biphasic,3 biphasic to prandial,4 and basal(+/-prandial) to biphasic5 insulin.
- HbA1c was generally similar except biphasic improved HbA1c more and got more people to a HbA1c ≤7.0% than basal in one study,3 but less than basal+prandial in another.5
- Basal insulin had significantly less hypoglycemia (than prandial2 or biphasic3) and weight gain (than biphasic3), and basal(+/-prandial) had less hypoglycemia and weight gain than biphasic.5
- Meta-analyses found similar.6,7
- 4T study1 is given priority because it is the largest, longest and compares the three options. Fortunately, the remaining studies2-5 generally support those findings.
- INSIGHT8 found initiating basal insulin in poorly controlled type 2 diabetes resulted in significantly lower HbA1C than continued oral hypoglycemic agents
- Mean HbA1c and hypoglycemic rates were not different between patients of family practitioners or diabetes experts.9
- There is no evidence that insulin is superior to oral agents in reducing clinical outcomes in patients with type 2 diabetes.10
- Specialists are five times more likely to initiate insulin than family practitioners.11